Product

CD14152

Aliases

CD14152 placebo

1 clinical trial

1 indication

Indication

Atopic Dermatitis

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to or for Whom Cyclosporine A is Not Medically Advisable

Status: Withdrawn, Estimated PCD: 2023-07-01